The initial factor in indicating the glioma variety is the isocitrate dehydrogenase (IDH) mutation status: glioblastoma—wild-type IDH (IHDwt) and oligodendroglioma or astrocytoma—IDH-mutant. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).